Silver Book Fact

New medicines, or “new chemical entities” accounted for 40% (0.8 years) of the two-year gain in life expectancy seen in 52 countries from 1986-2000.

Lichtenberg, Frank R. The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. National Bureau of Economic Research. June 2003; Working Paper No. 9754. http://www.nber.org/papers/w9754

Reference

Title
The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001
Publication
National Bureau of Economic Research
Publication Date
June 2003
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Benefit of Increased Health Care Spending: Disability rates declining for seniors, 1982-1999  
  • Decline in Disability Rates for People Aged over 65 Years, 1982-2000  
  • Spending $11,000 on general medical care adds an average of 1 year of life. Spending only $1,345 on pharmaceutical research and development yields the same return.  
  • Eliminating hypertension in all elderly persons would result in 75 million additional disability-adjusted life years (DALYs) and reduce Medicare spending by around $890 billion.  
  • Resonable disease prevention and management efforts could add $5.7 trillion to the nation’s economic output by 2050– a boost of 18%.